Synergy Pharmaceuticals Inc.

Apr 09, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP

Mar 06, 2019

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.

Feb 26, 2019

Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets

Feb 26, 2019

Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.

Dec 12, 2018

Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets

Dec 12, 2018

Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.

Feb 28, 2018

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Feb 12, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018